<DOC>
	<DOCNO>NCT00787644</DOCNO>
	<brief_summary>Asthmatics significantly overweight tend severe symptom , flare ups , likely poorly-controlled asthma compare asthmatic . Researchers believe occur excess adipose tissue ( fat ) bosy cause higher-than-normal level leptin low level adiponectin blood . The researcher study test medication call pioglitazone overweight asthmatic believe help regulate leptin adiponectin may improve symptom asthma .</brief_summary>
	<brief_title>Pilot Study Pioglitazone Treatment Moderate Severe Asthma Obese Asthmatics ( Glitz Asthma )</brief_title>
	<detailed_description>Participants study randomly assign ( like flip coin ) pioglitazone placebo ( inactive pill ) . They give study medication take every day 12 week ( 3 month ) . Participants complete number asthma-related questionnaire variety pulmonary function test . Participants undergo physical exam , electrocardiogram , blood sampling measure leptin , adiponectin , marker inflammation , blood cell count , glucose level , BNP hormone level , liver function . To monitor participant throughout study , follow-up visit do 2 , 6 , 12 week start study drug . At visit many pulmonary function test questionnaire repeat .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Asthma diagnose physician least 1 year prior study enrollment Poorlycontrolled asthma study enrollment Non smoker ( stop smoke least 1 year ago ) limit lifetime history smoking Body mass index 3060 Responds methacholine challenge test PC20 &lt; 16 mg/ml On stable dose inhale corticosteroid least 4 week prior study entry FEV1 &gt; 60 % predict Able obtain weekly weight home Systemic steroid within past 4 week Lung pathology asthma Other significant nonpulmonary comorbidities : coronary artery disease , peripheral vascular disease , cerebrovascular disease , congestive heart failure ejection fraction &lt; 50 % , liver disease elevate liver enzymes baseline , malignancy ( exclude nonmelanoma skin cancer ) , AIDS , renal failure serum creatinine &gt; 3.0 , disorder require steroid treatment vasculitis , lupus , rheumatoid arthritis Btype natriuretic peptide ( BNP ) &gt; 400pg/ml Pregnant lactate Currently take beta blocker , CYP2C8 inhibitor inducer gemfibrozil rifampin , TZD ( thiazolidinedione ) , allergic TZD Taking antioxidant ( take multivitamin must stable regimen prior enrollment ) Illicit drug use within past year Current/active upper respiratory infection ( active URI , wait asymptomatic 1 week enroll ) Asthma exacerbation within past 4 week ( include ER , urgent care , hospital visit due asthma result increase asthmarelated medication ) Undergoing evaluation sleep apnea , plan institute treatment sleep apnea ( patient stable treatment regimen sleep apnea last 3 month allow participate ) Clinically significant abnormality present screen 12lead electrocardiogram Women childbearing potential use oral contraceptive willing use second method contraception study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Adipose Tissue</keyword>
	<keyword>Asthmatics</keyword>
	<keyword>Pioglitazone</keyword>
	<keyword>Actos</keyword>
	<keyword>Obesity</keyword>
	<keyword>Exacerbation</keyword>
	<keyword>Fat</keyword>
	<keyword>Overweight</keyword>
	<keyword>Leptin</keyword>
	<keyword>Adiponectin</keyword>
	<keyword>Wheezing</keyword>
	<keyword>Vermont</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>Lung</keyword>
</DOC>